Sutro Biopharma (STRO) Enterprise Value (2017 - 2025)
Sutro Biopharma (STRO) reported Enterprise Value of -$141.4 million for Q4 2025, up 55.37% on a YoY basis from -$91.0 million in Q4 2024, and up 15.61% sequentially from -$167.6 million in Q3 2025.
Sutro Biopharma (STRO) Enterprise Value (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of Enterprise Value data on file, last reported at -$141.4 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 55.37% year-over-year to -$141.4 million; the trailing twelve-month figure through Dec 2025 stood at -$141.4 million (up 55.37% YoY), and the FY2025 full-year result was -$141.4 million, up 55.37% from the prior year.
- Enterprise Value grew to -$141.4 million in Q4 2025, from -$167.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$66.6 million in Q1 2022 to a low of -$388.3 million in Q3 2024.
- A 5-year average of -$218.5 million and a median of -$212.7 million in 2021 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 69.74% in 2022 and sank 277.32% in 2023, its largest moves.
- Tracing STRO's Enterprise Value over 5 years: stood at -$160.8 million in 2021, then tumbled by 88.08% to -$302.3 million in 2022, then surged by 63.22% to -$111.2 million in 2023, then sank by 184.96% to -$316.9 million in 2024, then surged by 55.37% to -$141.4 million in 2025.
- Business Quant data shows STRO's Enterprise Value at -$141.4 million in Q4 2025, -$167.6 million in Q3 2025, and -$205.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -141.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -141.43 Mn |
| Sep 30, 2025 | -167.59 Mn |
| Jun 30, 2025 | -205.13 Mn |
| Mar 31, 2025 | -248.97 Mn |
| Dec 31, 2024 | -316.90 Mn |
| Sep 30, 2024 | -388.25 Mn |
| Jun 30, 2024 | -375.57 Mn |
| Mar 31, 2024 | -267.60 Mn |
| Dec 31, 2023 | -111.21 Mn |
| Sep 30, 2023 | -115.88 Mn |
| Jun 30, 2023 | -268.44 Mn |
| Mar 31, 2023 | -251.47 Mn |
| Dec 31, 2022 | -302.34 Mn |
| Sep 30, 2022 | -287.34 Mn |
| Jun 30, 2022 | -191.63 Mn |
| Mar 31, 2022 | -66.65 Mn |
| Dec 31, 2021 | -160.76 Mn |
| Sep 30, 2021 | -189.94 Mn |
| Jun 30, 2021 | -91.67 Mn |
| Mar 31, 2021 | -220.27 Mn |